Xagenic Appoints Seasoned Industry Veteran Randall Wilhoite As Vice President Of Operations

TORONTO--(BUSINESS WIRE)--Xagenic, a molecular diagnostics company developing the Xagenic X1™ platform for use at the point of care, today announced that Randall Wilhoite has joined the Company as Vice President of Operations. Wilhoite will oversee manufacturing and operations to ensure the company's commercial objectives for the Xagenic X1 platform are met.

Suggested Articles

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Light Chain Bioscience, a unit of Swiss biotech Novimmune, has been handed a nice royalty milestone check from partner Takeda.

The fund received money from Chinese organizations inside and outside the biopharma industry, enabling CICC Capital to ease past its financing goal.